S&P Futures
4,280.50 +3.75 (+0.09%) Dow Futures
33,993.00 +30.00 (+0.09%) Nasdaq Futures
13,499.25 +6.00 (+0.04%) Russell 2000 Futures
1,993.80 +4.70 (+0.24%) Crude Oil
89.16 +1.05 (+1.19%) Gold
1,783.30 +6.60 (+0.37%)
ORIC Pharmaceuticals, Inc. (ORIC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 4.5900 |
| Open | 4.4400 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 1000 |
| Day's Range | 4.4400 - 4.8400 |
| 52 Week Range | 2.6200 - 26.7000 |
| Volume | |
| Avg. Volume | 301,727 |
| Market Cap | 186.802M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.2090 |
| Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ORIC
Related Research
- Oric Pharmaceuticals, Inc.Daily – Vickers Top Buyers & Sellers for 04/01/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat5 months agoArgus Research
- Zacks
Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914
Horizon (HZNP) enters into a collaboration and option agreement with Q32 Bio to develop the latter's ADX-914 for treating autoimmune diseases.
- GlobeNewswire
ORIC Pharmaceuticals Reports Second Quarter 2022Â Financial Results and Operational Update
Three ongoing single agent Phase 1 programs, ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers, and ORIC-944 in prostate cancer, all expected to report initial data in 1H 2023 Cash and investments of $237.8 million expected to fund current operating plan into 2H 2024 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeu
- Simply Wall St.
We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
